In Vitro Effects of Aminopyridyl Ligands Complexed to Copper(II) on the Physiology and Interaction Process of Trypanosoma cruzi
Leandro S. Sangenito,and K. Subba Reddy,Trinidad Velasco-Torrijos,André L.S. Santos,Marta H. Branquinha +4 more
TLDR
In this article , two aminopyridine derivatives, cis-aquadichloro(N-[4-(hydroxyphenyl)methyl]-2-pyridinemethamino)copper (3a) and its glycosylated ligand cis-dichloron (N-{[4-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyloxy)pheny]lmethyl}-2-Pyridine-copper(3b), are effective against T. cruzi trypomastigote forms.Abstract:
Chagas disease is derived from the infection by the protozoan Trypanosoma cruzi. In many countries, benznidazole is the only drug approved for clinical use despite several side effects and the emergence of resistant parasite strains. In this context, our group has previously pointed out that two novel aminopyridine derivatives complexed with Cu2+, namely, cis-aquadichloro(N-[4-(hydroxyphenyl)methyl]-2-pyridinemethamino)copper (3a) and its glycosylated ligand cis-dichloro (N-{[4-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyloxy)pheny]lmethyl}-2-pyridinemethamino)copper (3b), are effective against T. cruzi trypomastigote forms. With this result in mind, the present work aimed to investigate the effects of both compounds on trypomastigotes physiology and on the interaction process with host cells. Apart from loss of plasma membrane integrity, an increased generation of reactive oxygen species (ROS) and decreased mitochondrial metabolism were observed. Pretreatment of trypomastigotes with these metallodrugs inhibited the association index with LLC-MK2 cells in a typical dose-dependent manner. Both compounds showed low toxicity on mammalian cells (CC50 > 100 µM), and the IC50 values calculated for intracellular amastigotes were determined as 14.4 µM for 3a and 27.1 µM for 3b. This set of results demonstrates the potential of these aminopyridines complexed with Cu2+ as promising candidates for further antitrypanosomal drug development.read more
References
More filters
Journal ArticleDOI
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
TL;DR: A tetrazolium salt has been used to develop a quantitative colorimetric assay for mammalian cell survival and proliferation and is used to measure proliferative lymphokines, mitogen stimulations and complement-mediated lysis.
Journal ArticleDOI
Metallodrugs in Medicinal Inorganic Chemistry
Katja Dralle Mjos,Chris Orvig +1 more
Journal ArticleDOI
Chagas Disease: From Discovery to a Worldwide Health Problem
Kárita Cláudia Freitas Lidani,Fabiana Antunes Andrade,Lorena Bavia,Flávia Silva Damasceno,Marcia Holsbach Beltrame,Iara Messias-Reason,Thaisa Lucas Sandri,Thaisa Lucas Sandri +7 more
TL;DR: This review aims to describe the spread of CD cases worldwide since its discovery until it has become a global public health concern.
Journal ArticleDOI
Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities
Rodolfo Viotti,Carlos Vigliano,Bruno Lococo,María Gabriela Alvarez,Marcos Petti,Graciela Bertocchi,Alejandro Armenti +6 more
TL;DR: The efficacy and tolerance of benznidazole is inversely related to the age of the patient, while its side effects are more frequent in elderly patients, which means that the true clinical impact of the side effects could be different.
Journal ArticleDOI
Chagas Disease Drug Discovery: Toward a New Era
TL;DR: New developments in the Chagas field, including new technologies and tools now available, will be discussed, and a redesign of the current screening strategy during the discovery process is proposed.